Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroPort NeuroScientificHKSE:02172 +1.00%93 Buyback Yield % is 0.67 as of Aug. 25, 2026, which is 3% below its 10-year median of 0.69. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 331 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 75.23% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02172 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, MicroPort NeuroScientific's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroScientific Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroScientific's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort NeuroScientific (HKSE:02172) has a Buyback Yield % of 0.67 as of Aug. 25, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on MicroPort NeuroScientific and its competitors. This is near median its historical median of 0.69. Over the past decade, MicroPort NeuroScientific's Buyback Yield % has ranged from 0.11 to 2.38. According to the industry distribution chart, MicroPort NeuroScientific ranks #82 out of 331 companies in the Medical Devices & Instruments industry, placing it in the top 24.8%.
Is MicroPort NeuroScientific's Buyback Yield % too high?
MicroPort NeuroScientific's current Buyback Yield % of 0.67 is near median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 2.38. Based on the distribution chart, MicroPort NeuroScientific ranks #82 out of 331 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #82 out of 331 companies for Buyback Yield %. This places MicroPort NeuroScientific in the top 25% of its industry — outperforming the majority of peers. Historically, MicroPort NeuroScientific's own Buyback Yield % has ranged from 0.11 to 2.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on MicroPort NeuroScientific and its competitors. MicroPort NeuroScientific's current Buyback Yield % is 0.67, which is near median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.97, compared to a current price of HK$8.57 — trading 38.7% below its estimated fair value. The current Buyback Yield % is 0.67, which is near median its 10-year median of 0.69. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current Buyback Yield % is 0.67 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued.
The current stock price of HK$8.57 is trading 38.7% below its estimated GF Value™ of HK$13.97.
GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.
Key valuation signals for HKSE:02172:
Buyback Yield %: 0.67 (near median its 10-year median of 0.69)
GF Value™: HK$13.97 vs. price of HK$8.57 (38.7% below fair value)
No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score
Get the complete analysis for HKSE:02172
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02172 has been successfully added to your 
